Tetraphase Pharmaceuticals, Inc.
TTPH
TTPH was delisted on the 28th of July, 2020.
90 hedge funds and large institutions have $76.6M invested in Tetraphase Pharmaceuticals, Inc. in 2016 Q3 according to their latest regulatory filings, with 10 funds opening new positions, 25 increasing their positions, 28 reducing their positions, and 11 closing their positions.
0% more call options, than puts
Call options by funds: $288K | Put options by funds: $288K
9% less first-time investments, than exits
New positions opened: 10 | Existing positions closed: 11
1% less funds holding
Funds holding: 91 → 90 (-1)
11% less repeat investments, than reductions
Existing positions increased: 25 | Existing positions reduced: 28
18% less capital invested
Capital invested by funds: $93.8M → $76.6M (-$17.2M)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
NI
Numeric Investors
Boston,
Massachusetts
|
+$2.03M |
| 2 |
RSCM
Rock Springs Capital Management
Baltimore,
Maryland
|
+$951K |
| 3 |
Northern Trust
Chicago,
Illinois
|
+$897K |
| 4 |
D.E. Shaw & Co
New York
|
+$771K |
| 5 |
AC
Armistice Capital
New York
|
+$729K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
GPP
Great Point Partners
Greenwich,
Connecticut
|
-$7.4M |
| 2 |
Canada Pension Plan Investment Board
Toronto Ontario,
Ontario, Canada
|
-$1.29M |
| 3 |
Wellington Management Group
Boston,
Massachusetts
|
-$686K |
| 4 |
DCM
DAFNA Capital Management
Los Angeles,
California
|
-$446K |
| 5 |
CC
Clearline Capital
New York
|
-$437K |
TTPH Hedge Fund Activity: Q3 2016 in Review
90 of the 3,748 institutional investors tracked by Wall St. Rank reported a position in Tetraphase Pharmaceuticals, Inc. (TTPH) for Q3 2016, worth a combined $76.6M — down 18% from $93.8M a quarter earlier.
Sellers outnumbered buyers: 11 funds closed out of TTPH and 10 opened new positions — a net loss of 1 holder — while 28 trimmed existing stakes and 25 added.
The largest buyer was Numeric Investors, opening a new position worth an estimated $2.03M. The largest seller was Great Point Partners, cutting an estimated $7.4M.
- 90 institutional investors held Tetraphase Pharmaceuticals, Inc. (TTPH) as of Q3 2016, down from 91 in Q2 2016.
- Funds reported $76.6M of Tetraphase Pharmaceuticals, Inc. stock for Q3 2016, down 18% quarter-over-quarter.
- 10 funds opened new Tetraphase Pharmaceuticals, Inc. positions in Q3 2016 and 11 closed out, a net change of -1 holder.
- The largest Tetraphase Pharmaceuticals, Inc. buyer in Q3 2016 was Numeric Investors, an estimated $2.03M added.
- The largest Tetraphase Pharmaceuticals, Inc. seller in Q3 2016 was Great Point Partners, an estimated $7.4M sold.
Based on aggregated 13F filings for Q3 2016.